RadNet, Inc. (RDNT) Stock

RadNet, Inc. (RDNT) is a Healthcare stock trading at $53.73 (as of 2026-06-18), with a market capitalization of $4.37B and a trailing P/E of -326.6. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.

RadNet, Inc. provides outpatient diagnostic imaging services in the United States, offering modalities such as MRI, CT, PET, nuclear medicine, mammography, ultrasound, and related radiology procedures. It also develops and supplies imaging-industry computer systems and provides AI solutions, including support for mammography and applications in lung and prostate cancer.

Valuation — source: SEC EDGAR (first-party)
Price	$53.73
Market Cap	$4.37B
P/E Ratio	-326.6
EV / EBITDA	22.3
Price / Book	3.23
Price / Sales	2.04
DCF Value (model)	$92.99
DCF Upside vs Price	73.1%

Profitability & Growth — source: SEC EDGAR
Revenue (TTM)	$2.04B
Net Margin	-0.9%
Return on Equity	-1.0%
Debt / Equity	0.80
Current Ratio	1.17
Revenue Growth (YoY)	22.1%
EPS Growth (YoY)	-15.7%

Financial Health — source: SEC EDGAR
Altman Z-Score	1.75 (distress)

Valuation vs Sector & Industry
Stock P/E	-326.6
Sector P/E (Healthcare)	21.0
Industry P/E (Healthcare Services)	23.0
vs Sector	-1658.5%
vs Industry	-1518.1%

Smart-Money Activity — SEC Form 4 / 13F / Congressional disclosures
Top Institutional Holder	BlackRock, Inc. ($560.90M)
Institutional Holders Tracked	10

Company
Sector	Healthcare
Industry	Healthcare Services
CEO	Howard G. Berger
Employees	11,000
Country	US
IPO Date	1997-01-03

Related Companies (Business model: Clinical Labs / CRO Services; 8 closest by market cap; US-domiciled)

Data as of 2026-06-18.

Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.